Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. (Q48469829)
Jump to navigation
Jump to search
scientific article published in May 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. |
scientific article published in May 1998 |
Statements
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma (English)
S S Legha
S Ring
A Bedikian
A C Buzaid
C Plager